IP Library Granted Patent US 8,044,203
Granted Patent B2
US 8,044,203 · App. 12/577,958 · Granted Oct 25, 2011

Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups

Assignees: Carnegie Mellon University; GE Healthcare UK Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,044,203
App. No.
12/577,958
Granted
Oct 25, 2011
Kind
B2
Abstract

This invention relates to the functionalized cyanine dyes and more particularly, to the synthesis of chiral 3-substituted 2,3′-dimethyl-3H-indole and its derivatives as intermediates for preparation of cyanine dyes, to methods of preparing these dyes and the dyes so prepared.

Claims (20)

1. A compound of the following general formula (XIV)

wherein:

R a , R c , R d , and R f are independently selected from V or L-V where

L is a bond or C 1-22 straight or branched alkyl, optionally containing 0, 1 or 2 unsaturations or unsaturated pendent or interchain groups selected from alkenyl, alkynyl and aryl groups;

V is selected from hydrogen, halogen, —OH, —NH 2 , —SH, —CN, trifluoromethyl, —SO 3 − , phosphate, phosphonate, quaternary ammonium, —NO 2 , mono- or di-nitro-substituted benzyl, —COOH, and —NHCOR g , where R g is C 1-20 straight or branched alkyl; a target bonding group, reactive group, reactive moiety, or NHR h where R h is H, C 1-20 straight or branched alkyl or COOH;

T is

wherein each L and V are independently as defined above;

Y is selected from the group consisting of O, S, —CH═CH—, >C(CH 3 ) 2 ,

and —N—(CH 2 ) 1-10 X, wherein X is selected from —COOH, —NH 2 , —SO 3 − , —OH and halogen;

Z a and Z b are independently, fused

and p, u, v and r are independently an integer from 0-4, and at least one V must be —COOH in at least one of T and Y.

2. A compound of claim 1 wherein said reactive group is selected from:

where n is an integer of 1-10, and at least one of Q or W is a leaving group selected from the group consisting of I, Br and Cl.

3. A method of detecting any one of an antibody, protein, peptide, enzyme substrate, hormone, lymphokine, metabolite, receptor, antigen, hapten, lectin, avidin, streptavidin, toxin, carbohydrate, oligosaccharide, polysaccharide, nucleic acid, derivatized deoxy nucleic acid, DNA fragment, RNA fragment, derivatized DNA fragment, derivatized RNA fragment, nucleoside, nucleotide, natural drug, synthetic drug, virus particle, bacterial particle, virus component, yeast component, blood cell, blood cell component, plasma component, serum component, biological cell, noncellular blood component, bacteria, bacterial component, natural or synthetic lipid vesicle, poison, environmental pollutant, polymer, polymer particle, glass particle, glass surface, plastic particle, plastic surface, polymer membrane, conductor or semiconductor comprising detecting a compound of claim 1 bound to said antibody, protein, peptide, enzyme substrate, hormone, lymphokine, metabolite, receptor, antigen, hapten, lectin, avidin, streptavidin, toxin, carbohydrate, oligosaccharide, polysaccharide, nucleic acid, derivatized deoxy nucleic acid, DNA fragment, RNA fragment, derivatized DNA fragment, derivatized RNA fragment, nucleoside, nucleotide, natural drug, synthetic drug, virus particle, bacterial particle, virus component, yeast component, blood cell, blood cell component, plasma component, serum component, biological cell, noncellular blood component, bacteria, bacterial component, natural or synthetic lipid vesicle, poison, environmental pollutant, polymer, polymer particle, glass particle, glass surface, plastic particle, plastic surface, polymer membrane, conductor or semiconductor.

4. A method of detecting any one of an antibody, protein, peptide, enzyme substrate, hormone, lymphokine, metabolite, receptor, antigen, hapten, lectin, avidin, streptavidin, toxin, carbohydrate, oligosaccharide, polysaccharide, nucleic acid, derivatized deoxy nucleic acid, DNA fragment, RNA fragment, derivatized DNA fragment, derivatized RNA fragment, nucleoside, nucleotide, natural drug, synthetic drug, virus particle, bacterial particle, virus component, yeast component, blood cell, blood cell component, plasma component, serum component, biological cell, noncellular blood component, bacteria, bacterial component, natural or synthetic lipid vesicle, poison, environmental pollutant, polymer, polymer particle, glass particle, glass surface, plastic particle, plastic surface, polymer membrane, conductor or semiconductor comprising detecting a compound of claim 2 bound to said antibody, protein, peptide, enzyme substrate, hormone, lymphokine, metabolite, receptor, antigen, hapten, lectin, avidin, streptavidin, toxin, carbohydrate, oligosaccharide, polysaccharide, nucleic acid, derivatized deoxy nucleic acid, DNA fragment, RNA fragment, derivatized DNA fragment, derivatized RNA fragment, nucleoside, nucleotide, natural drug, synthetic drug, virus particle, bacterial particle, virus component, yeast component, blood cell, blood cell component, plasma component, serum component, biological cell, noncellular blood component, bacteria, bacterial component, natural or synthetic lipid vesicle, poison, environmental pollutant, polymer, polymer particle, glass particle, glass surface, plastic particle, plastic surface, polymer membrane, conductor or semiconductor.

5. A method of analysis or detection comprising analyzing or detecting a sample comprising a compound according to claim 1 or a conjugate of a component comprising the same.

6. A method of analysis or detection comprising analyzing or detecting a sample comprising a compound according to claim 2 or a conjugate of a component comprising the same.

7. The method of claim 5 where said detecting is by optical means.

8. The method of claim 6 where said detecting is by optical means.

9. A compound selected from the group consisting of 6-[9-(5-carboxypentyl)-5,7-dimethyl-5,11-disulfo-1,2,9,14,15,16,15a,16a,2a-nonahydroindolo-[2″,1″-1′,2′]isoquinolino[7′,6′-4,3]pyridino[1,2-a]indolin-7-yl/hexanoic acid, and 6,7,9,10-tetrahydro-2,14-disulphonato-16,16,18-trimethyl-7aH,8aH-bisindolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-5-ium-18-hexanoic acid.

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 8, 2022
From: CARNEGIE-MELON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061896/0313 →
CONFIRMATORY LICENSE Recorded Feb 22, 2016
From: CARNEGIE MELLON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 037785/0522 →
Continuity (3)
Division 10513141
Provisional Application 60379107 · May 10, 2002
Related Publication 20100267008A1 · Oct 21, 2010